Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $24.95 -0.76%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $30.00 (from $36.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Dyne Therapeutics to present DMD preclinical data at NMSG meeting
- CLSA Upgrades Taiyo Yuden Co Ltd (6976:JP) (TYOYY) to High-Conviction Outperform (1)
- CLSA Downgrades Heineken Malaysia Bhd (HEIM:MK) to Hold (3)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
